Vestal Point Capital, LP: holdings and changes

Number 63 of the top 100 funds by copy return. Vestal Point Capital, LP reported 63 US stocks worth $3.9B for the quarter ending 2026-09-30 and changed 15 new, 22 added, 19 trimmed and 20 sold since 2026-06-30.

Copy return, 4 quarters+43.4%
US 500, same time+14.5%
Size$3.9B
Stocks63

Holdings

StockChangeWeightValueShares
ABVX
Abivax Sa-Adr
ADD +69%10.13%$392M3,960,000
NBIX
Neurocrine Biosciences INC
ADD +33%9.16%$355M2,500,000
BMRN
Biomarin Pharmaceutical INC
TRIM -8%8.56%$332M5,525,000
ARWR
Arrowhead Pharmaceuticals, INC.
ADD +206%8.14%$315M4,815,000
INSM
Insmed INC.
ADD +990%8.04%$311M2,725,000
UTHR
United Therapeutics Corp
ADD +9%6.65%$257M475,000
ASND
Ascendis Pharma A/S
ADD +97%4.36%$169M740,000
NRIX
Nurix Therapeutics INC
TRIM -13%4.30%$167M7,025,000
TARS
Tarsus Pharmaceuticals INC
ADD +94%4.13%$160M2,033,625
ELVN
Enliven Therapeutics INC
TRIM -19%3.82%$148M3,225,000
IRON
Disc Medicine INC
ADD +5%2.77%$107M1,635,000
BCAX
Bicara Thera INC
ADD +5%2.66%$103M5,525,000
DYN
Dyne Therapeutics INC
ADD +84%2.58%$100M6,200,000
IMTX
Immatics N.V
ADD +81%2.54%$98M11,200,000
TSHA
Taysha Gene Therapies INC Com Shs
TRIM -7%2.27%$88M18,045,000
GLUE
Monte Rosa Therapeutics INC
ADD +55%2.20%$85M7,130,000
GMED
Globus Med INC Cl A
ADD +8%1.77%$68M915,000
CBIO
Crescent Biopharma INC.
ADD +84%1.13%$44M3,000,000
ZBH
Zimmer Hldgs INC Com
TRIM -66%1.09%$42M475,000
TVTX
Travere Therapeutics INC
BUY0.91%$35M600,000
RCUS
Arcus Biosciences INC
BUY0.87%$34M1,300,000
XENE
Xenon Pharmaceuticals INC
ADD +21%0.82%$32M850,000
NKTR
Nektar Therapeutics
TRIM -49%0.80%$31M510,000
DRUG
Bright Minds Biosciences INC
0.70%$27M545,000
BBIO
Bridgebio Pharma INC
BUY0.68%$26M400,000
IMCR
Immunocore Holdings Limited
TRIM -53%0.67%$26M850,000
PODD
Insulet Corp
TRIM -74%0.59%$23M175,000
TRVI
Trevi Therapeutics
TRIM -52%0.55%$21M1,495,000
SNY
Sanofi Adr
TRIM -75%0.53%$21M500,000
SVRA
Savara INC
ADD +21%0.44%$17M3,300,000
SGP
Spyglass Pharma INC
TRIM -4%0.43%$17M640,000
ZYME
Zymeworks INC
BUY0.41%$16M600,000
COGT
Cogent Biosciences INC
BUY0.39%$15M475,000
SLDB
Solid Biosciences INC
TRIM -3%0.39%$15M2,085,000
LXEO
Lexeo Therapeutics INC
0.38%$15M4,320,000
AVTX
Avalo Therapeutics INC
ADD +3%0.32%$12M800,000
ZBIO
Zenas Biopharma INC
ADD +8%0.28%$11M395,000
EVMN
Evommune INC
ADD +25%0.27%$10M1,250,000
VKTX
Viking Therapeutics INC
TRIM -57%0.24%$10M290,000
STOK
Stoke Therapeutics INC
BUY0.23%$9M345,000
KRSA
Korsana Biosciences INC
BUY0.22%$8M263,105
DMRA
Damora Therapeutics INC Com Shs
BUY0.22%$8M395,000
TECX
Tectonic Therapeutic INC
TRIM -15%0.22%$8M360,000
ZURA
Zura Bio LTD
ADD +58%0.20%$8M1,860,000
GKOS
Glaukos Corp
BUY0.19%$7M45,000
KLRA
Kailera Therapeutics INC
ADD +9%0.18%$7M625,000
AVR
Anteris Technologies Global
TRIM -16%0.17%$7M850,000
MLTX
Moonlake Immunot
BUY0.16%$6M525,000
RZLT
Rezolute INC
ADD +280%0.16%$6M1,455,000
TRAX
First Tracks Biotherapeutics
TRIM -83%0.16%$6M169,738
VYGR
Voyager Therapeutics INC
TRIM -18%0.15%$6M2,165,000
MAZE
Maze Therapeutics
BUY0.12%$5M175,000
OLEMA PHARMACE
Olema Pharmaceut
0.09%$4M420,000
PALI
Palisade Bio INC
0.09%$3M2,500,000
ENGN
Engene Therapeut
0.09%$3M1,665,000
NGNE
Neurogene INC Com
BUY0.08%$3M115,000
IBIO
Ibio INC
0.08%$3M2,600,000
AVBP
Arrivent Biopharma INC
BUY0.08%$3M100,000
OKUR
Onkure Therapeutics INC
TRIM -40%0.08%$3M1,088,000
CTMX
Cytomx Therapeutics INC
BUY0.04%$2M535,000
OCS
Oculis Holding Ag
BUY0.03%$1M132,000
NYXOAH SA NPV
Nyxoah Sa Npv Isin Be0974358906 Sedol Bn
TRIM -43%0.02%$700k479,000
APRE
Aprea Therapeutics INC
0.01%$300k350,000
Abbot Labs
Abbot Labs
SELL0%was $127M0
Astrazeneca Pl
Astrazeneca PLC Ord
SELL0%was $85M0
RVMD
Revolution Medicines INC
SELL0%was $84M0
BCRX
Biocryst Pharmaceuticals INC
SELL0%was $83M0
RGEN
Repligen INC.
SELL0%was $55M0
BMY
Bristol Myers Squibb Co
SELL0%was $46M0
QURE
Uniqure Nv
SELL0%was $43M0
MDGL
Madrigal Pharmaceuticals INC
SELL0%was $35M0
ALC
Alcon INC
SELL0%was $34M0
MYGN
Myriad Genetics
SELL0%was $33M0
RAPP
Rapport Therapeutics INC
SELL0%was $30M0
GEHC
Ge Healthcare Technologies I
SELL0%was $29M0
BBNX
Beta Bionics INC
SELL0%was $25M0
REGN
Regeneron Pharmaceuticals INC Com
SELL0%was $25M0
ANRO
Alto Neuroscience INC
SELL0%was $21M0
GALECTO INC
Galecto INC
SELL0%was $15M0
SRZN
Surrozen INC
SELL0%was $8M0
MNPR
Monopar Therapeutics INC
SELL0%was $7M0
SGMT
Sagimet Biosciences INC.
SELL0%was $4M0
TENX
Tenax Therapeutics INC
SELL0%was $800k0

Copy return each quarter

HeldFund copyUS 500
2024-03-31 → 2024-06-30+1.0%+4.0%
2024-06-30 → 2024-09-30+5.7%+5.4%
2024-09-30 → 2024-12-31-3.3%+2.1%
2024-12-31 → 2025-03-31-8.5%-4.6%
2025-03-31 → 2025-06-30-0.1%+10.5%
2025-06-30 → 2025-09-30+42.7%+7.8%
2025-09-30 → 2025-12-31+27.6%+2.4%
2025-12-31 → 2026-03-31+7.3%-4.6%
2026-03-31 → 2026-06-30+14.6%+14.8%
2026-06-30 → 2026-09-30-8.6%+2.1%

The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.

All top 100 funds, live

Other top funds

Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP